Neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype

Journal of Virology

Volumn 70, Issue 11, 1996, Pages 7827-7832

  Weber, Jonathan ^a   Fenyö, Eva Maria ^b   Beddows, Simon ^a   Kaleebu, Pontiano ^a   Björndal, Åsa ^b   Osmanov, S ^c   Heyward, W ^c   Esparza, J ^c   Galvao Castro, B ^d   Van De Perre, P ^e   Karita, E ^e   Wasi, C ^f   Sempala, S ^g   Tugume, B ^g   Biryahwaho, B ^g   Rubsamen Waigmann H ^h   Von Briesen, H ^h   Esser, R ^h   Grez, M ^h   Holmes, H ⁱ   Newberry, A ⁱ   Ranjhar, S ⁱ   Tomlinson, P ⁱ   Bradac, J ^j   more..

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNAIDS   (Switzerland)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e National Reference Laboratory   (Rwanda)

^f MAHIDOL UNIVERSITY   (Thailand)

^g UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^h INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

ⁱ NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^j NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAZIL; CONTROLLED STUDY; GEOGRAPHY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; RWANDA; SEROTYPING; THAILAND; UGANDA; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS TITRATION; VIRUS TYPING;

EID: 10244249213     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.11.7827-7832.1996     Document Type: Article

References (26)

1. Albert, J., B. Abrahamsson, K. Nagy, E. Aurelins, H. Gaines, G. Nystrom, and E. M. Fenyö. 1990. Rapid development of isolate-specific neutralising antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralisation by autologous sera. AIDS 4:107-112.
2. Albert, J., E. Björling, A. von Gegerfelt, G. Scarlatti, Y. J. Zhang, E. M. Fenyö, and R, Thorstensson. 1993. Antigen detection is a reliable method for evaluating HIV/SIV neutralization assays. AIDS Res. Hum. Retroviruses 9:501-504.
3. Ariyoshi, K., E. Harwood, R. Cheingsong-Popov, and J. Weber. 1992. Is clearance of HIV-I viraemia at seroconversion mediated by neutralising antibodies? Lancet 340:1257-1258.
4. Berman, P., S. Beddows, L. Riddle, P. Kaleebu, D. Eastman, F. Wurm. T. Gregory, R. Cheingsong-Popov, and J. Weber. Relationship between genetic subtype and antigenic structure of HIV-1 envelope glycoproteins assessed with antisera to rgp120 from diverse isolates. AIDS, in press.
5. Cheingsong-Popov, R., S. Lister, D. Callow, P. Kaleebu, S. Beddows, and J. Weber. 1994. Serotyping HIV-1 through antibody binding to the V3 loop: relationship to viral genotype. AIDS Res. Hum. Retroviruses 10:1379-1385.
6. Coffin J. 1986. Genetic variation in AIDS viruses. Cell 45:1-4.
7. Delwart, E. L., E. G. Shpaer, J. Louwagie, F. E. McCutchan, M. Grez, H. Rubsamen-Waigmann, and J. I. Mullins. 1993. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science 262:1257-1261.
8. D'Souza, M. P., G. Milman, J. A. Bradac, D. McPhee, C. V. Hanson, R. M. Hendry, and Collaborating Investigators. 1995. Neutralization of primary HIV-1 isolates by anti-envelope monoclonal antibodies. AIDS 9:867-874.
9. Fiscus, S. A., V. DeGruttola, P. Gupta, D. A. Katzenstein, W. A. Meyer III, M. L. LoFaro, M. Katzman, M. V. Ragni, P. S. Reichelderfer, and R. W. Coombs. 1995. Human immunodeficiency virus type 1 quantitative cell microculture as a measure of antiviral efficacy in a multicenter clinical trial. J. Infect. Dis. 171:305-311.
10. Gao, F., L. Yue, S. Craig, C. L. Thornton, D. L. Robertson, F. E. McCutchan, J. A. Bradac, P. M. Sharp, B. H. Hahn, and the WHO Network for HIV Isolation and Characterisation. 1994. Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C and E. AIDS Res. Hum. Retroviruses 10:1359-1364.
11. Kostrikis, L. G., Y. Cao, H. Ngal, J. P. Moore, and D. D. Ho. 1996. Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement. J. Virol. 70:445-458.
12. Louwagie, J., F. McCutchan, M. Peeters, T. P. Brennan. E. Sanders-Buell, G. A. Eddy G. van der Groen, K. Fransen, G. M. Gershy-Damet, R. Deleys, and D. S. Burke. 1993. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 7:769-780.
13. Mascola, J., J. Louwagie, F. McCutchan, C. L. Fischer, P. A. Hegerich, K. F. Wagner, A. K. Fowler, J. G. McNeil, and D. S. Burke. 1994. Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotypes predicts neutralization serotype. J. Infect. Dis. 169:48-54.
14. McKeating, J. A., Y.-J. Zhang, C. Arnold, R. Frederiksson, E.-M. Fenyö, and P. Balfe. Chimeric viruses expressing primary envelope glycoproteins of human immunodeficiency virus type 1 show increased sensitivity to neutralization by human sera. Virology, in press.
15. Moore, J. 1992. MRC ADP reagent catalogue. Medical Research Council, London.
16. Moore, J. P., Y. Cao, J. Leu, L. Qin, B. Korber, and D. D. Ho. 1996. Inter-and intraclade neutralization of human immunodeficiency virus type 1: genetic eludes do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes. J. Virol. 70:427-444.
17. MRC/ANRS Delta Virology Committee. Unpublished data
18. Myers, G., A. B. Robson, J. A. Berzofsky, and T. F. Smith (ed.). 1991 and 1992. Human retroviruses and AIDS. A compilation of nucleic acid and amino acid sequences. Los Alamos National Laboratory, Los Alamos, N.Mex.
19. Ou, C. Y., Y. Takebe, B. G. Weniger, S. Yamazaki, H. D. Gayle, N. L. Young, and G. Schochetman. 1993. Independent introduction of two major HIV-1 genotypes into distinct high risk populations in Thailand. Lancet 341:1171-1174.
20. Sawyer, L., M. T. Wrin, L. Crawford-Miksza, B. Potts, Y. Wu, P. A. Weber, R. D. Alfonso, and C. V. Hanson. 1994. Neutralisation sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated. J. Virol. 68:1342-1349.
21. Sharp, P. M., D. L. Robertson, F. Gao, and B. H. Hahn. 1994. Origins and diversity of human immunodeficiency viruses. AIDS 8(Suppl. 1):S27-S42.
22. Spouge, J. L. 1992. Statistical analysis of sparse infection data and its implications for retroviral treatment trials in primates. Proc. Natl. Acad. Sci. USA 89:7581-7585.
23. Sundqvist, V. A., J. Albert, E. Ohlsson, J. Hinluka, E. M. Fenyö, and B. Wahren. 1989. Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics. J. Med. Virol. 29:170-175.
24. Weber, J. N., R. Cheingsong-Popov, D. Callow, S. Adams, G. Patou, K. Hodgkin, S. Martin, F. Gotch, and A. Kingsman. 1995. Immunogenicity of the yeast recombinant p17/p24:Ty virus-like particles (p24-VLP) in healthy volunteers. Vaccine 13(9):831-834.
25. Weiss, R. A., P. R. Clapham, R. Cheingsong-Popov, A. G. Dalgleish, C. A. Carne I. V. D. Weller, and R. S. Tedder. 1985. Neutralisation of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients. Nature (London) 316:68-72.
26. WHO Network for HIV Isolation and Characterisation. 1994 HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. AIDS Res. Hum. Retroviruses 10:1327-1345.